PART 3Amendment of Part 3 (manufacture and distribution of medicinal products and active substances)
Amendment of Schedule 5 (review upon oral representations)I122
1
Schedule 5 M1 is amended as follows.
2
In paragraph 1(2)(e), 3(11)(b) and 5(2)(d) after—
a
“UK marketing authorisation,” in each place it appears, insert “
parallel import licence,
”
; and
b
“an authorisation,” or “the authorisation,” in each place it appears, insert “
licence,
”
.
3
In paragraph 3 omit sub-paragraph (11)(b)(iii).
4
In paragraph 5 omit sub-paragraph (2)(c).